One-Hour Oral Glucose Tolerance Tests for the Prediction and Diagnostic Surveillance of Type 1 Diabetes.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 11 2020
Historique:
received: 21 08 2020
accepted: 21 08 2020
pubmed: 28 8 2020
medline: 17 2 2021
entrez: 27 8 2020
Statut: ppublish

Résumé

Once islet autoantibody-positive individuals are identified, predicting which individuals are at highest risk for type 1 diabetes (T1D) is important. A metabolic risk score derived from 2-hour oral glucose tolerance test (OGTT) data, the Diabetes Prevention Trial-Type 1 risk score (DPTRS), can accurately predict T1D. However, 2-hour OGTTs are time-consuming and costly. We aimed to determine whether a risk score derived from 1-hour OGTT data can predict T1D as accurately as the DPTRS. Secondarily, we evaluated whether a 1-hour glucose value can be used for diagnostic surveillance. The DPTRS was modified to derive a 1-hour OGTT risk score (DPTRS60) using fasting C-peptide, 1-hour glucose and C-peptide, age, and body mass index. Areas under receiver operating curves (ROCAUCs) were used to compare prediction accuracies of DPTRS60 with DPTRS in Diabetes Prevention Trial-Type 1 (DPT-1) (n = 654) and TrialNet Pathway to Prevention (TNPTP) (n = 4610) participants. Negative predictive values (NPV) for T1D diagnosis were derived for 1-hour glucose thresholds. ROCAUCs for T1D prediction 5 years from baseline were similar between DPTRS60 and DPTRS (DPT-1: 0.805 and 0.794; TNPTP: 0.832 and 0.847, respectively). DPTRS60 predicted T1D significantly better than 2-hour glucose (P < .001 in both cohorts). A 1-hour glucose of less than 180 mg/dL had a similar NPV, positive predictive value, and specificity for T1D development before the next 6-month visit as the standard 2-hour threshold of less than 140 mg/dL (both ≥ 98.5%). A 1-hour OGTT can predict T1D as accurately as a 2-hour OGTT with minimal risk of missing a T1D diagnosis before the next visit.

Identifiants

pubmed: 32844178
pii: 5897237
doi: 10.1210/clinem/dgaa592
pmc: PMC7514797
pii:
doi:

Substances chimiques

Autoantibodies 0
Blood Glucose 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDDK NIH HHS
ID : U01 DK085476
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061010
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085499
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085463
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK103266
Pays : United States
Organisme : NIDDK NIH HHS
ID : UC4 DK106993
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061042
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085509
Pays : United States
Organisme : NIDDK NIH HHS
ID : UC4 DK117009
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085466
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK103153
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061058
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085505
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085453
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061034
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085461
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK103180
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085465
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085504
Pays : United States

Informations de copyright

© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Diabetes Care. 2005 May;28(5):1068-76
pubmed: 15855569
Stat Med. 2013 Dec 30;32(30):5381-97
pubmed: 24027076
Diabetes Care. 2008 Nov;31(11):2188-92
pubmed: 18650369
N Engl J Med. 2002 May 30;346(22):1685-91
pubmed: 12037147
JAMA. 2020 Jan 28;323(4):339-351
pubmed: 31990315
Diabetes Care. 2014 Apr;37(4):979-84
pubmed: 24550217
Diabetes Care. 2017 Nov;40(11):1494-1499
pubmed: 28860125
Curr Diab Rep. 2015 Aug;15(8):49
pubmed: 26077017
Pediatr Diabetes. 2016 Sep;17(6):441-8
pubmed: 26251221
Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28
pubmed: 30559228
Diabetes Care. 2015 Oct;38(10):1964-74
pubmed: 26404926
J Clin Endocrinol Metab. 2010 Jul;95(7):3360-7
pubmed: 20444913
Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1701-6
pubmed: 10677521
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17040-5
pubmed: 17942684
Diabetes. 2010 Oct;59(10):2386-9
pubmed: 20682683
Diabetes. 2001 Feb;50(2):470-6
pubmed: 11272162
Pediatr Diabetes. 2019 Nov;20(7):909-914
pubmed: 31376227

Auteurs

Kimber M Simmons (KM)

Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, Colorado, USA.

Jay M Sosenko (JM)

Division of Endocrinology, University of Miami, Miami, Florida, USA.

Megan Warnock (M)

University of South Florida, Tampa, Florida, USA.

Susan Geyer (S)

University of South Florida, Tampa, Florida, USA.

Heba M Ismail (HM)

Department of Pediatrics, Indiana University, Indianapolis, Indiana, USA.

Helena Elding Larsson (H)

Department of Clinical Sciences and Department of Pediatrics, Skåne University Hospital, Malmö, Sweden.

Andrea K Steck (AK)

Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, Colorado, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH